Theravance Equity Dashboard

The Equities Center is a collection of modules for individual equity research and analysis. You can examine different market driven as well as company specific characteristics using powerful cross-assets modules such as watch-list analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerful tools. Please select from the options below.
Theravance -- USA Stock  

USD 9.81  9.81  9,223,372,036,855%

Quote & Profile

Quote & Profile

Theravance profile, quote, and daily performance
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for Theravance
Event Calendar

Event Calendar

Calendar of corporate events and headlines for Theravance
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for Theravance
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for Theravance
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for Theravance
Chance of Bankruptcy

Chance of Bankruptcy

Theravance chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different Theravance historical pattern-recognition indicators
Current Valuation

Current Valuation

Theravance valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

Theravance current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze Theravance Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

Theravance volatility and risk analysis compared to market
Correlation With Market

Correlation With Market

Theravance correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

Theravance in the context of related companies
Management

Management

Theravance leadership and management evaluation
Performance

Performance

Risk adjusted expected returns and performance analysis
Risk-adjusted Recommendation

Risk-adjusted Recommendation

Personalized buy or sell advice on Theravance
Power Widgets

Power Widgets

Macroaxis widgets syndication for Theravance
Price Prediction

Price Prediction

Basic Theravance price forecast based on headlines and hype
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for Theravance
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of Theravance
Fundamental History

Fundamental History

Theravance history of fundamentals from various financial
Revenue

Revenue

Relative Theravance revenue analysis
Net Loss Analysis

Net Loss Analysis

Theravance loss analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on Theravance operations
This is a quick snapshot of Theravance research areas. You can expand your research by examining different market driven as well as company specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and and many other powerfull tools.

Current Sentiment - THRX

Theravance Investor Sentiment
Most of Macroaxis users are at this time bullish on Theravance. What is your outlook on investing in Theravance? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
2 days ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
2 days ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
2 days ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
2 days ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
2 days ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
2 days ago
Traded for 23.82
Also please take a look at World Market Map. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.